[go: up one dir, main page]

DK1146117T3 - En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus - Google Patents

En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus

Info

Publication number
DK1146117T3
DK1146117T3 DK00201326T DK00201326T DK1146117T3 DK 1146117 T3 DK1146117 T3 DK 1146117T3 DK 00201326 T DK00201326 T DK 00201326T DK 00201326 T DK00201326 T DK 00201326T DK 1146117 T3 DK1146117 T3 DK 1146117T3
Authority
DK
Denmark
Prior art keywords
preparing
treatment
diabetes mellitus
matures
mature
Prior art date
Application number
DK00201326T
Other languages
English (en)
Inventor
Daniel Pipeleers
Original Assignee
Beta Cell N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Cell N V filed Critical Beta Cell N V
Application granted granted Critical
Publication of DK1146117T3 publication Critical patent/DK1146117T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00201326T 2000-04-12 2000-04-12 En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus DK1146117T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201326A EP1146117B1 (en) 2000-04-12 2000-04-12 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
CA2363971A CA2363971C (en) 2000-04-12 2001-11-26 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
DK1146117T3 true DK1146117T3 (da) 2008-05-26

Family

ID=32070512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00201326T DK1146117T3 (da) 2000-04-12 2000-04-12 En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus

Country Status (8)

Country Link
US (1) US6686197B2 (da)
EP (1) EP1146117B1 (da)
AT (1) ATE384781T1 (da)
CA (1) CA2363971C (da)
DE (1) DE60037876T2 (da)
DK (1) DK1146117T3 (da)
ES (1) ES2299417T3 (da)
PT (1) PT1146117E (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002359390A1 (en) * 2001-11-09 2003-05-19 Artecel Sciences, Inc. Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
WO2003068357A2 (en) * 2002-02-12 2003-08-21 Cornell Research Foundation, Inc. Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
SI1636348T1 (sl) 2003-06-20 2010-01-29 Vrije Universiteit Brussel Vub Postopek za pridobivanje beta celic iz eksokrinskih celic trebuĺ ne slinavke
AU2012237375A1 (en) 2011-03-29 2013-10-10 Beta-Cell Nv Method for encapsulated therapeutic products and uses thereof
EP2771693A1 (en) * 2011-10-28 2014-09-03 Centre National de la Recherche Scientifique (CNRS) Process of diagnostic, prognostic and therapeutic monitoring of solid tumors
CA2923504A1 (en) * 2013-09-19 2015-03-26 Beta-Cell Nv Method for the treatment of diabetes mellitus
MX384445B (es) 2013-09-24 2025-03-14 Giner Inc Sistema para tratamiento con gas de un implante de células.
CA3043468C (en) 2016-11-15 2021-06-22 Giner Life Sciences, Inc. Percutaneous gas diffusion device suitable for use with a subcutaneous implant
US11642501B2 (en) 2017-05-04 2023-05-09 Giner, Inc. Robust, implantable gas delivery device and methods, systems and devices including same
CN116121172A (zh) * 2023-03-14 2023-05-16 武汉远赞吉诺百客医学科技有限公司 一种猪胰腺单细胞悬液制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5050612A (en) * 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
US5858973A (en) * 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US6110743A (en) * 1995-02-10 2000-08-29 The Regents Of The University Of California Development and use of human pancreatic cell lines

Also Published As

Publication number Publication date
ATE384781T1 (de) 2008-02-15
CA2363971A1 (en) 2003-05-26
US6686197B2 (en) 2004-02-03
CA2363971C (en) 2011-10-11
ES2299417T3 (es) 2008-06-01
EP1146117A1 (en) 2001-10-17
EP1146117B1 (en) 2008-01-23
DE60037876D1 (de) 2008-03-13
US20020177228A1 (en) 2002-11-28
DE60037876T2 (de) 2009-01-29
PT1146117E (pt) 2008-05-06

Similar Documents

Publication Publication Date Title
WO2002040630A3 (en) Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
DK1146117T3 (da) En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus
BR0311362A (pt) métodos, composições e fatores de crescimento e de diferenciação para produzir células produtoras de insulina
BRPI0519783A2 (pt) composições imunogênicas de pvc2 e métodos de produzir tais composições
DK1311658T3 (da) Fremgangsmåde til fremstilling af brugsfærdige, eventuelt antigenholdige cryokonserverede modne dendritiske celler
DE50210575D1 (de) In-vitro-verfahren zum herstellen einer homologen "gestenteten" tissue engineerten herzklappe
AU2001282123A1 (en) Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
DK1165791T3 (da) Humant cytokin som zalpha-receptor-ligand og anvendelse deraf
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
DK0970701T3 (da) Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
ATE195555T1 (de) Verfahren zur herstellung transformierter zellen
BR0209494A (pt) Células-t reativadas para imunoterapia adotiva
NZ592159A (en) Means and methods for influencing the stability of antibody producing cells
NO20053357L (no) Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.
SG137871A1 (en) In vitro techniques for use with stem cells
TW200617394A (en) Porcine reproductive and respiratory syndrome isolates and methods of use
WO2002043779A3 (en) Use of acacia gum (arabic gum) to isolate and preserve biological material
CA2380943A1 (en) Mechanically elongated neuronal cells and methods for producing and using these cells
WO2005054447A3 (en) Müller stem cells
WO2008092440A3 (de) Therapeutische zusammensetzung und verwendung einer zellfreien substanz
ATE297981T1 (de) Herstellung von vakzinen unter der verwendung von hybrid-zellen
AU2002241277A1 (en) Functional plant, promoter to be used for producing the functional plant and method of using the same
TW200420530A (en) Novel method for preparing methyl 2-diphenylmethylsulfinylacetate
TW200721980A (en) Method for producing fermented milk, and fermented milk